Meperidine hydrochloride; promethazine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for meperidine hydrochloride; promethazine hydrochloride and what is the scope of patent protection?
Meperidine hydrochloride; promethazine hydrochloride
is the generic ingredient in one branded drug marketed by Hikma and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for meperidine hydrochloride; promethazine hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 2 |
DailyMed Link: | meperidine hydrochloride; promethazine hydrochloride at DailyMed |
Recent Clinical Trials for meperidine hydrochloride; promethazine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Albert Einstein Healthcare Network | N/A |
University of California, Irvine | N/A |
See all meperidine hydrochloride; promethazine hydrochloride clinical trials
US Patents and Regulatory Information for meperidine hydrochloride; promethazine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | MEPERGAN | meperidine hydrochloride; promethazine hydrochloride | INJECTABLE;INJECTION | 011730-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |